Prolactin-inducible EDD E3 ubiquitin ligase promotes TORC1 signalling, anti-apoptotic protein expression, and drug resistance in breast cancer cells.

MacDonald, Tyler M; Thomas, Lynn N; Daze, Emily; Marignani, Paola; Barnes, Penelope J; Too, Catherine Kl

MacDonald, Tyler M; Thomas, Lynn N; Daze, Emily; Marignani, Paola; Barnes, Penelope J; Too, Catherine Kl.

Afiliación

MacDonald TM; Department of Biochemistry & Molecular Biology, Faculty of Medicine, Dalhousie University Halifax, NS, Canada.
Thomas LN; Department of Biochemistry & Molecular Biology, Faculty of Medicine, Dalhousie University Halifax, NS, Canada.
Daze E; Department of Biochemistry & Molecular Biology, Faculty of Medicine, Dalhousie University Halifax, NS, Canada.
Marignani P; Department of Biochemistry & Molecular Biology, Faculty of Medicine, Dalhousie University Halifax, NS, Canada.
Barnes PJ; Department of Pathology, Faculty of Medicine, Dalhousie University Halifax, NS, Canada.
Too CK; Department of Pathology, Faculty of Medicine, Dalhousie University Halifax, NS, Canada.

Am J Cancer Res ; 9(7): 1484-1503, 2019.

Article en En | MEDLINE | ID: mdl-31392083

Palabras clave

EDD E3 ubiquitin ligase; TORC1; apoptosis; breast cancer; drug resistance; prolactin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Am J Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google